As of 11:44am ET
| +0.06 / +5.50%|
The 2 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.25, with a high estimate of 4.00 and a low estimate of 2.50. The median estimate represents a +182.61% increase from the last price of 1.15.
The current consensus among 2 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.